ADVENTRX Completes Acquisition of SynthRx
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
Profiles
CeQur Develops Diabetes Compliance Device
An important drawback of current diabetes treatment regimens is patient compliance, particularly for insulin injections that are painful and must also be timely administered.
Accord Biosciences To Present At OneMedForum NY 2011
Nitric oxide is one of the most important physiological signaling molecules in the body, responsible for regulating such fundamental biological processes as proper blood vessel function and the body’s defense against infection.
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
Is Europe A Better Place To Build A Medical Technology Company? (Video)
Growth in the life sciences industries will greatly depend on how the FDA responds to growing complaints that they are stifling medical technologies.
S.E.A. Medical Tackles IV Errors Before They Occur
In 2006, 2-year-old Emily Jerry was killed when a technician mixed her chemotherapy drug with a saline solution 26 times above normal.
ECI Biotech Can Sense Infection
An innovative approach to wound care, ECI Biotech makes simple and affordable sensors, branded, ExpressDetect, that turn blue in the presence of harmful microbial pathogens.
Killing Canine Cancer:Functional Nutriments Applies Ground-Breaking Therapy To Human Patients (Video)
Cancer, a word that strikes a chord of fear in many, is a fighting word. At $47.7bn, cancer is one of the largest, fastest growing markets in the pharmaceutical industry, and while it is a match we have yet to win, researchers and scientists have on their boxing gloves and are staying in the fight.
Hunting Disease In The Dark: MEDomics Seeks to Treat Mitochondrial Disease Before It Occurs
The core theory behind preventative medicine is almost psychic. To stop a disease from wielding its mighty weapons before it occurs is based on foreknowledge of a patient’s susceptibility to the illness.
A Heart To Heart Talk On The Future Of Cardiology (Video)
According to the American Heart Association, more than 13 million people suffer from coronary heart disease, 6 million from angina, and 7 million from myocardial infraction. Rapid technological advances and product innovation are transforming the cardiology market.